Human Pathology
Volume 36, Issue 5 , Pages 531-535 , May 2005

The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma

  • Nathalie Rioux-Leclercq, MD, PhD

      Affiliations

    • Département d'Anatomie et de Cytologie Pathologiques, Faculté de Médecine, 35043 Rennes Cedex 9, France
    • Corresponding Author InformationCorresponding author. Département d'Anatomie et de Cytologie Pathologiques, Faculté de Médecine, 2 Avenue du Professeur Léon Bernard, 35043 Rennes Cedex 9, France.
    • ,
  • Emmanuelle Leray, MSc

      Affiliations

    • Département de Santé Publique, Centre Hospitalo–Universitaire Pontchaillou, 35033 Rennes Cedex 9, France
    • ,
  • Jean-Jacques Patard, MD, PhD

      Affiliations

    • Service d'Urologie, Centre Hospitalo–Universitaire Pontchaillou, 35033 Rennes Cedex 9, France
    • ,
  • Bernard Lobel, MD

      Affiliations

    • Service d'Urologie, Centre Hospitalo–Universitaire Pontchaillou, 35033 Rennes Cedex 9, France
    • ,
  • François Guillé, MD

      Affiliations

    • Service d'Urologie, Centre Hospitalo–Universitaire Pontchaillou, 35033 Rennes Cedex 9, France
    • ,
  • Florence Jouan, RT

      Affiliations

    • Département d'Anatomie et de Cytologie Pathologiques, Faculté de Médecine, 35043 Rennes Cedex 9, France
    • ,
  • Pascale Bellaud, RT

      Affiliations

    • Département d'Anatomie et de Cytologie Pathologiques, Faculté de Médecine, 35043 Rennes Cedex 9, France
    • ,
  • Jonathan I. Epstein, MD

      Affiliations

    • Departments of Pathology, Urology and Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA

Received 12 January 2005 ,Accepted 19 January 2005.

References 

  1. Bock BJ, Bostwick DG. Does prostatic ductal adenocarcinoma exist?. Am J Surg Pathol. 1999;23:781–785
  2. Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy. Correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol. 1999;23:1471–1479
  3. Samaratunga H, Singh M. Distribution pattern of basal cells detected by cytokeratin 34 beta E12 in primary prostatic duct adenocarcinoma. Am J Surg Pathol. 1997;21:435–440
  4. Bostwick DG, Kindrachuck RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features: Clinical, pathologic and ultrastructural findings. Am J Surg Pathol. 1985;9:595–609
  5. Bostwick DG, Brawer MK. Prostatic intraepithelial neoplasia and early invasion in prostate cancer. Cancer. 1987;59:788–794
  6. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol. 1993;24:298–310
  7. Cheng CJ, Chen KC, Chen WY, Su SJ. Ductal adenocarcinoma of the prostate with endometrioid features in a 69-year-old man. J Formos Med Assoc. 2001;100:707–711
  8. Colpaert C, Gentens P, Van Marck E. Ductal “endometrioid” adenocarcinoma of the prostate. Acta Urol Belg. 1998;66:29–32
  9. Rubin MA, de La Taille A, Bagiella E, Olsson CA, O'Toole KM. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia. Incidence and clinical implications. Am J Surg Pathol. 1998;22:840–848
  10. Weinstein MH, Epstein JI. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol. 1993;24:624–629
  11. Wilcox G, Soh S, Chakraborty S, Scardino PT, Wheeler TM. Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum Pathol. 1998;29:1119–1123
  12. Keetch DW, Humphrey P, Stahl D, Smith DS, Catalona WJ. Morphometric analysis and clinical follow-up of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol. 1995;154:347–351
  13. Kronz JD, Allan CH, Shaikh AA, Epstein JI. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy. Data on men with more than one follow-up biopsy. Am J Surg Pathol. 2001;25:1079–1085
  14. Cristensen WN, Steinberg G, Walsh PC, Epstein JI. Prostatic duct adenocarcinoma: Findings at radical prostatectomy. Cancer. 1991;67:2118–2124
  15. Mc Neal JE, Yemoto CEM. Spread of adenocarcinoma within prostatic ducts and acini. Am J Surg Pathol. 1996;20:802–814
  16. Mellicow MM, Patcher MR. Endometrial carcinoma of prostate utricle (uterus masculinus). Cancer. 1967;20:1715–1721
  17. Drake WM, Burrows S. Papillary carcinoma of prostatic ducts. Urology. 1974;3:621–623
  18. Dawkins HJ, Sellner LN, Turbett GR, et al. Distinction between intraductal carcinoma of the prostate (ICD-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Prostate. 2000;44:265–270
  19. Randolph TL, Amin MB, Ro JY, Ayala AG. Histologic variants of adenocarcinoma and other carcinomas of the prostate: Pathologic criteria and clinical significance. Mod Pathol. 1997;10:612–629
  20. Kronz JD, Shaikh AA, Epstein JI. Atypical cribriform lesions on prostate biopsy. Am J Surg Pathol. 2001;25:147–155
  21. Goldstein NS, Underhill J, Roszka J, et al. Cytokeratin 34 betaE-12 immunoreactivity in benign prostatic acini: Quantitation, pattern assessment, and electron microscopy study. Am J Clin Pathol. 1999;112:69–74
  22. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features: A light microscopic and immunohistochemical study of ten cases. Cancer. 1986;57:111–119
  23. Millar EK, Sharma NK, Lessells AM. Ductal (endometrioid) adenocarcinoma of the prostate: A clinicopathological study of 16 cases. Histopathology. 1996;29:11–19
  24. Oxley JD, Abbot CD, Gillatt DA, MacIver AG. Ductal carcinomas of the prostate: A clinicopathological and immunohistochemical study. Br J Urol. 1998;81:109–115
  25. Kunju LP, Rubin MA, Chinnaiyan AM, Shah RB. Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations. Am J Clin Pathol. 2003;102:737–745
  26. Sanderson SO, Sebo TJ, Murphy LM, Neumann R, Slezak J, Cheville JC. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays. Am J Clin Pathol. 2004;121:220–225
  27. Beach R, Gown AM, De Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 2002;26:1588–1596
  28. Brown DC, Gatter KC. Monoclonal antibody Ki67: Its use in histopathology. Histopathology. 1990;17:489–503
  29. Gerdes J. Ki-67 and other proliferation markers useful for immunohistochemical diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol. 1990;1:199–206
  30. Mengel M, von Wasielewski R, Wiese B, Rudiger T, Muller-Hermelink HK, Kreipe H. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labeling index in a large multi-centre trial. J Pathol. 2002;198:292–299
  31. Haussler O, Epstein JI, Amin MB, Heitz PU, Hailemariam S. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer. Hum Pathol. 1999;30:1077–1086
  32. Munoz E, Gomez F, Paz JI, et al. Ki-67 immunolabeling in pre-malignant lesions and carcinoma of the prostate. Histological correlation and prognostic evaluation. Eur J Histochem. 2003;47:123–128
  33. Tamboli P, Amin MB, Schultz DS, Linden MD, Kubus J. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Mod Pathol. 1996;9:1015–1019
  34. Tsuji M, Kanda K, Murakami Y, et al. Biologic markers in prostatic intraepithelial neoplasia: Immunohistochemical and cytogenetic analyses. J Med Invest. 1999;46:35–41

PII: S0046-8177(05)00049-3

doi: 10.1016/j.humpath.2005.01.021

Human Pathology
Volume 36, Issue 5 , Pages 531-535 , May 2005

Article Tools

* Image Usage & Resolution